FDA Inspection 991871 — Piedmont Reproductive Endocrinology Group, PA
The FDA completed an inspection of Piedmont Reproductive Endocrinology Group, PA on Nov 9, 2016 in Spartanburg, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 9, 2016
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Spartanburg, SC (United States)